S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE III NCRI FLAIR TRIAL

Bibliographic Details
Main Authors:	P. Hillmen, A. Pitchford, A. Bloor, A. Pettitt, P. Patten, F. Forconi, A. Schuh, C. Fox, N. Elmusharaf, S. Gatto, B. Kennedy, J. Gribben, N. Pemberton, O. Sheehy, G. Preston, D. Howard, A. Hockaday, D. Cairns, S. Jackson, N. Greatorex, N. Webster, S. Dalal, J. Shingles, K. Cwynarski, S. Paneesha, D. Allsup, A. Rawstron, T. Munir
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843472.57904.29

Internet